Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review
Introduction: Adverse drug reactions (ADR) are an important cause of morbidity and mortality in pediatric patients. Due to the disease severity and chemotherapy safety profile, oncologic patients are at higher risk of ADR. However, there is little evidence on pharmacovigilance studies evaluating dru...
Saved in:
Main Authors: | Kristopher Amaro-Hosey (Author), Immaculada Danés (Author), Antònia Agustí (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service
by: Kristopher Amaro-Hosey, et al.
Published: (2021) -
Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system
by: Francesca Filippi-Arriaga, et al.
Published: (2023) -
Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos Systematic review of studies assessing the cost of adverse drug reactions
by: Antonio Vallano Ferraz, et al.
Published: (2012) -
Corrigendum: Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
by: Carolina Iglesias-Lopez, et al.
Published: (2020) -
Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union
by: Carolina Iglesias-Lopez, et al.
Published: (2021)